Aarti Drugs Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

394.60 -1.80 (-0.45%)Updated : 13 Jul 2026

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	2,323.09	2,152.58	2,259.01	2,456.93
Other Net	2.39	0.30	-3.36	-3.41
Total Adjustmentsto Net Income	0.00	-	-	-
Diluted Weighted Average Shares	9.13	9.16	9.19	9.26
Depreciation/ Amortization	66.97	55.78	51.45	50.32
Operating Income	242.22	234.45	269.57	259.13
Net Income	194.92	168.16	171.42	166.31
Income Availableto Com Excl Extra Ord	194.92	168.16	171.42	166.31
Other Operating Expenses Total	508.08	9.37	9.11	9.14
Net Income Before Taxes	210.90	211.77	235.53	224.18
Minority Interest	-0.02	0.06	-0.17	-0.05
Net Income After Taxes	194.94	168.10	171.59	166.36
Income Availableto Com Incl Extra Ord	194.92	168.16	171.42	166.31
Costof Revenue Total	1,618.72	1,857.86	1,996.95	2,201.43
Gross Profit	946.59	529.17	531.62	514.62
Interest Inc( Exp) Net- Non- Op Total	-33.71	-22.98	-30.50	-31.54
Diluted Net Income	194.92	168.16	171.42	166.31
Provisionfor Income Taxes	15.96	43.67	63.94	57.82
period Type	-	-	-	-
Net Income Before Extra Items	194.92	168.16	171.42	166.31
Total Revenue	2,565.31	2,387.03	2,528.58	2,716.05
period Length	12.00	12.00	12.00	12.00
Revenue	2,565.31	2,387.03	2,528.58	2,716.05
Selling/ General/ Admin Expenses Total	129.32	216.53	193.15	191.38
Diluted Normalized EPS	21.36	18.35	18.66	17.96
Diluted EPS Excluding Extra Ord Items	21.36	18.35	18.65	17.96
Gain( Loss)on Saleof Assets	-	0.00	-0.18	-
DPS- Common Stock Primary Issue	-	1.00	1.00	1.00
Research Development	-	13.04	8.35	4.66

*All figures in crores except per share values

Trending Stocks

2,182.00+112.95(5.46%)

1,225.00+62.35(5.36%)

1,102.50+34.45(3.23%)

187.25-3.90 (-2.04%)

285.00-4.65 (-1.61%)

Related News